EVALUATION OF A NEW TRIPHASIC ORAL-CONTRACEPTIVE IN PRIVATE-PRACTICE

被引：12

作者：

ELLSWORTH, HS ^{[1
]}

AYERST, RI ^{[1
]}

HARRIS, JW ^{[1
]}

STONE, RA ^{[1
]}

ANDERSON, AE ^{[1
]}

JONES, TL ^{[1
]}

CURTIS, MK ^{[1
]}

机构：

[1] BROWNE MCHARDY CLIN,METAIRIE,LA

来源：

关键词：

D O I：

10.1016/0010-7824(86)90053-3

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：435 / 442

页数：8

共 10 条

[1] CARBORG L, 1983, CONTRACEPTION, V27, P439
[2] Consensus Conference, 1985, JAMA, V253, P2080
[3] PLASMA-HORMONE LEVELS IN WOMEN RECEIVING NEW ORAL-CONTRACEPTIVES CONTAINING ETHINYL ESTRADIOL PLUS LEVONORGESTREL OR DESOGESTREL
GASPARD, UJ
ROMUS, MA
GILLAIN, D
DUVIVIER, J
DEMEYPONSART, E
FRANCHIMONT, P
[J]. CONTRACEPTION, 1983, 27 (06) : 577 - 590
[4] OVARIAN-FUNCTION IS EFFECTIVELY INHIBITED BY A LOW-DOSE TRIPHASIC ORAL-CONTRACEPTIVE CONTAINING ETHINYLESTRADIOL AND LEVONORGESTREL
GASPARD, UJ
DUBOIS, M
GILLAIN, D
FRANCHIMONT, P
DUVIVIER, J
[J]. CONTRACEPTION, 1984, 29 (04) : 305 - 318
[5] KADISH AH, 1965, CLIN CHEM, V11, P869
[6] LARSSONCOHN U, 1981, FERTIL STERIL, V35, P167
[7] POWELL MG, 1984, OBSTET GYNECOL, V63, P764
[8] THE SHORT-TERM EFFECTS OF A LOW-DOSE ORAL-CONTRACEPTIVE ON GLUCOSE-METABOLISM, PLASMA-LIPIDS AND BLOOD-CLOTTING FACTORS
SKOUBY, SO
WAGNER, HH
ANDERSEN, O
[J]. CONTRACEPTION, 1983, 28 (05) : 489 - 499
[9] SPELLACY WN, 1982, AM J OBSTET GYNECOL, V142, P732
[10] WYNN V, 1982, AM J OBSTET GYNECOL, V142, P739